Akorn Offloads Consumer Health For $230m

All-Cash Deal Allows Beleaguered Firm To Invest In Optimizing Prescription Business

 
• By David Wallace
  
Akorn website magnifying glass
Akorn has struck a $230m deal for its consumer healthcare business • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business